Cargando…
Aspirin-triggered resolvin D1 reduces parasitic cardiac load by decreasing inflammation in a murine model of early chronic Chagas disease
BACKGROUND: Chagas disease, caused by the protozoan Trypanosoma cruzi, is endemic in Latin America and is widely distributed worldwide because of migration. In 30% of cases, after years of infection and in the absence of treatment, the disease progresses from an acute asymptomatic phase to a chronic...
Autores principales: | Carrillo, Ileana, Rabelo, Rayane Aparecida Nonato, Barbosa, César, Rates, Mariana, Fuentes-Retamal, Sebastián, González-Herrera, Fabiola, Guzmán-Rivera, Daniela, Quintero, Helena, Kemmerling, Ulrike, Castillo, Christian, Machado, Fabiana S., Díaz-Araya, Guillermo, Maya, Juan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631674/ https://www.ncbi.nlm.nih.gov/pubmed/34784372 http://dx.doi.org/10.1371/journal.pntd.0009978 |
Ejemplares similares
-
Simvastatin Improves Cardiac Function through Notch 1 Activation in BALB/c Mice with Chronic Chagas Cardiomyopathy
por: Guzmán-Rivera, Daniela, et al.
Publicado: (2020) -
Resolvin D1 and Aspirin-Triggered Resolvin D1 Regulate Histamine-stimulated Conjunctival Goblet Cell Secretion
por: Li, Dayu, et al.
Publicado: (2013) -
Pleiotropic antifibrotic actions of aspirin-triggered resolvin D1 in the lungs
por: Guilherme, Rafael F., et al.
Publicado: (2023) -
Effect of statins on inflammation and cardiac function in patients with chronic Chagas disease: A protocol for pathophysiological studies in a multicenter, placebo-controlled, proof-of-concept phase II trial
por: Campos-Estrada, Carolina, et al.
Publicado: (2023) -
Predictive modeling of aspirin‐triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome
por: Yellepeddi, Venkata Kashyap, et al.
Publicado: (2019)